US FDA Raises Problems With EU Data Protection Reg, But Are They Among Those Misunderstanding It?

An FDA blog post says some inspections have been hindered and application assessments soon could be delayed by the EU General Data Protection Regulation (GDPR), but experts argue the law includes directions to allow data sharing and remain compliant.

data protection
An FDA official said its application assessments could be affected by the GDPR. • Source: Shutterstock

More from Clinical Trials

More from R&D